LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

Inicio・Lista de Acciones・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Cerrado

SectorSalud

33.96 0.15

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

33.32

Máximo

34.1

Métricas clave
By Trading Economics
Ingresos	11M 51M
Ventas	39M 239M
P/B Media del Sector	10.038 105.69
BPA	1.08
Margen de beneficio	21.242
Empleados	268
EBITDA	12M 71M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+35.17% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	145M 1.8B
Apertura anterior	33.81
Cierre anterior	33.96

Noticias sobre sentimiento de mercado

By Acuity

34%

66%

104 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

29.8 / N/A Soporte y Resistencia

Harmony Biosciences Holdings Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

18 nov 2025, 19:25 UTC

Adquisiciones, fusiones, absorciones

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- 2nd Update

18 nov 2025, 18:09 UTC

Adquisiciones, fusiones, absorciones

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- Update

18 nov 2025, 17:39 UTC

Adquisiciones, fusiones, absorciones

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough

18 nov 2025, 16:25 UTC

Principales Movimientos del Mercado

Diginex Rises on Deal With Digital Asset Platform Evident

18 nov 2025, 23:56 UTC

Charlas de Mercado

Gold Edges Higher on Likely Technical Recovery -- Market Talk

18 nov 2025, 23:39 UTC

Charlas de Mercado

Nikkei May Rise on Bargain-Hunting Interest -- Market Talk

18 nov 2025, 22:59 UTC

Charlas de Mercado

FireFly Metals Can Build Bigger Operation at Green Bay -- Market Talk

18 nov 2025, 22:08 UTC

Charlas de Mercado

Sandfire's Kalkaroo Project Push Adds to Copper M&A Surge -- Market Talk

18 nov 2025, 22:03 UTC

Adquisiciones, fusiones, absorciones

Meta Defeats FTC's Antitrust Case Alleging Social-Media Monopoly -- 3rd Update

18 nov 2025, 22:03 UTC

Ganancias

These Stocks Moved the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18 nov 2025, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

18 nov 2025, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

18 nov 2025, 21:15 UTC

Charlas de Mercado

Private High-Grade Credit Market Is Changing, BlackRock Says -- Market Talk

18 nov 2025, 20:46 UTC

Charlas de Mercado

U.S. Natural Gas Futures Edge Up on Weather Outlook -- Market Talk

18 nov 2025, 20:13 UTC

Charlas de Mercado

Distillate Supply Concerns Pull Crude Futures Higher -- Market Talk

18 nov 2025, 19:48 UTC

Charlas de Mercado

Gold and Silver Turn Lower on Fed Outlook -- Market Talk

18 nov 2025, 19:19 UTC

Adquisiciones, fusiones, absorciones

Anheuser-Busch InBev Nears $700 Million Deal for Party Punch Maker BeatBox -- WSJ

18 nov 2025, 19:19 UTC

Adquisiciones, fusiones, absorciones

Anheuser-Busch InBev in Talks to Buy Party Punch Maker BeatBox, Sources Say -- WSJ

18 nov 2025, 19:19 UTC

Adquisiciones, fusiones, absorciones

AB InBev-BeatBox Deal Could Come Together Soon, Sources Say -- WSJ

18 nov 2025, 19:19 UTC

Adquisiciones, fusiones, absorciones

AB InBev Deal Would Value BeatBox At Around $700M, Sources Say -- WSJ

18 nov 2025, 18:29 UTC

Ganancias

These Stocks Are Moving the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18 nov 2025, 18:18 UTC

Charlas de Mercado

Ethanol Demand Expected to Boost Corn Futures -- Market Talk

18 nov 2025, 17:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

18 nov 2025, 17:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

18 nov 2025, 17:19 UTC

Charlas de Mercado

Ganancias

Good Weather Was Bad News for Home Depot's 3Q -- Market Talk

18 nov 2025, 17:06 UTC

Ganancias

Medtronic Stock Rises After Earnings. What Caught Investors' Attention. -- Barrons.com

18 nov 2025, 16:06 UTC

Adquisiciones, fusiones, absorciones

Intuit Stock Gains on OpenAI Deal. ChatGPT Is Coming to TurboTax. -- Barrons.com

18 nov 2025, 15:59 UTC

Ganancias

Home Depot Cuts Outlook as Home Improvement Slowdown Continues -- Update

18 nov 2025, 15:35 UTC

Adquisiciones, fusiones, absorciones

Eni: Acquisition Adds to Plenitude's Installed-Capacity Targets, Bolsters France Presence

18 nov 2025, 15:35 UTC

Adquisiciones, fusiones, absorciones

Eni: Portfolio Comprises Capacity of Around 760MW in Operation

Comparación entre iguales

Cambio de precio

Harmony Biosciences Holdings Inc Esperado

Precio Objetivo

By TipRanks

35.17% repunte

Estimación a 12 meses

Media 46 USD 35.17%

Máximo 62 USD

Mínimo 32 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Harmony Biosciences Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

10 ratings

Comprar

Mantener

Vender

De acuerdo con 10 analistas que ofrecen calificaciones bursátiles a para Harmony Biosciences Holdings Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

29.8 / N/ASoporte y Resistencia

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentimiento

By Acuity

104 / 374 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.